show episodes
 
Citeline places biopharma and medical device professionals, and those who focus on these industries, at the forefront of knowledge and insight, by providing the perfect combination of news and information together with penetrating insight and analysis. Citeline is a leader in the field of healthcare industry information.
  continue reading
 
Artwork

1
Digital Pathology Podcast

Aleksandra Zuraw, DVM, PhD

Unsubscribe
Unsubscribe
매달+
 
Aleksandra Zuraw from Digital Pathology Place discusses digital pathology from the basic concepts to the newest developments, including image analysis and artificial intelligence. She reviews scientific literature and together with her guests discusses the current industry and research digital pathology trends.
  continue reading
 
Artwork

1
Deep Pharma Intelligence

Deep Pharma Intelligence

Unsubscribe
Unsubscribe
매일+
 
Deep Pharma Intelligence (DPI) is a leading strategic and investment intelligence agency focused on the emerging markets in the Pharmaceutical, BioTech, and Healthcare Tech industries. DPI is producing regular analytical reports on major areas of high-potential in the pharmaceutical and healthcare industries, maintaining ratings of companies and governments based on their innovation potential and business activity in the BioTech space, and providing strategic consulting and investment intell ...
  continue reading
 
Artwork

1
The Future of Pharma

Samir Gondalia, ISPE Boston

Unsubscribe
Unsubscribe
매달
 
The Future of Pharma with ISPE Boston. Find out where the pharmaceutical industry is headed and what it means for you. Join host Samir Gondalia as he chats with the thought leaders of the pharma world about the new technologies, innovative applications and emerging markets and how it’s going to influence the future of Pharma.
  continue reading
 
Discover the transformative power of GenAI, Data Analytics, Social Intelligence, and Physician Influencer Marketing that is shaping the future of pharma marketing. Join us, as we pave the pathway to a novel pharma marketing landscape, bringing to you conversations that meet at the intersection of technology and marketing. Hosted by Saumya Prakash, Co-Founder Multiplier AI Solutions, this podcast is spearheading the dialogues on disruptions in pharma marketing. Know more about us at: https:// ...
  continue reading
 
Intelligent Automation – a powerful confluence of Process Intelligence, Intelligent Document Processing, RPA, Low Code/No Code application development, and Intelligent Virtual Agents, built on a stack of Advanced Intelligence capabilities, powered by Generative AI and supported by Next-gen Infrastructure. It empowers enterprises to drive integrated human experience outcomes, powered by agile configurable workflows.
  continue reading
 
A weekly podcast discussion about asymmetric learning - how organisations gain competitive advantage through their approach to learning, in all its forms. We will talk with thought leaders and experts to understand processes and systems of learning that lead to outperformance.
  continue reading
 
American Healthcare Entrepreneurs and Execs you might want to know. Talking. Relentless Health Value is a weekly interview podcast hosted by Stacey Richter, a healthcare entrepreneur celebrating fifteen years in the business side of healthcare. This show is for leaders in pharma, devices, payers, providers, patient advocacy and healthcare business. It's for health industry innovators, entrepreneurs or wantrepreneurs or intrapreneurs. Relentless Healthcare Value is the show for you if you wan ...
  continue reading
 
Get knowledge and inspiration to apply artificial intelligence to drug development. Discover startups applying machine learning to biomedical research. Hear how biotech and pharma companies use AI to speed discovery and cut costs. Learn from academic researchers pushing boundaries in applying computation to biology. We interview leaders transforming drug development with data and algorithms. Subscribe now and never miss an episode!
  continue reading
 
Artwork

1
AI50

Hanh Brown

Unsubscribe
Unsubscribe
매일+
 
AI50 navigates the forefront of technology, delving into the nuances of artificial intelligence, especially focusing on Microsoft's Fabric and Azure AI platforms. Each episode illuminates the latest in scientific innovation, with a special lens on how these advancements interface with the aging population. We unravel the complexities of AI and technology's role in society, providing deep insights and thoughtful analysis. Join us as we explore the ever-changing world of technology, unveiling ...
  continue reading
 
Science Will Win is a podcast that takes listeners under the microscope of some of the most promising medical innovations, exploring therapies that have the potential to shape the future of healthcare and offer new hope to patients around the world. Through conversations with a diverse line-up of guests, including scientists and experts, patient advocates, and, most importantly, patients themselves, each miniseries will focus on a unique healthcare challenge, diving into the fascinating scie ...
  continue reading
 
Are you working in healthcare market research or competitive intelligence or market intelligence? Do you often face information overload, from the pharma news portals, clinical trial registries, regulatory agencies, financial reports, investor releases, pharma summits, investment news, and financial summits etc.? It is hard to keep a track of all the forces (external and internal) that affects a product’s development and performance in the healthcare/ pharmaceutical market. We at RAS Life Sc ...
  continue reading
 
Clarivate Conversations in Healthcare is a collection of candid interviews with key leaders and experts. Veteran industry journalist Mike Ward explores business challenges and opportunities the industry currently faces, including COVID-19, clinical innovation, deal making, emerging market dynamics, data and technology, new engagement models, patient centricity and much more. Hosted on Acast. See acast.com/privacy for more information.
  continue reading
 
Exploring all things genetics. Dr Patrick Short, University of Cambridge alumnus and CEO of Sano Genetics, analyses the science, interviews the experts, and discusses the latest findings and breakthroughs in genetic research. To find out more about Sano Genetics and its mission to accelerate the future of precision medicine visit: www.sanogenetics.com
  continue reading
 
Augmented Ops is a podcast for industrial leaders, shop floor operators, citizen developers, and anyone else that cares about what the future of frontline operations will look like across industries. We equip our listeners with the knowledge to understand the latest advancements at the intersection of manufacturing and technology, as well as actionable insights that they can implement in their own operations. This show is presented by Tulip, the Frontline Operations Platform.
  continue reading
 
Loading …
show series
 
Good morning from Pharma and Biotech Daily, the podcast that gives you only what's important to hear in Pharma and Biotech world.Sanofi beat third-quarter forecasts with a 381% growth in sales of its newly launched respiratory syncytial virus antibody, Beyfortus, bringing in almost $700 million. Analysts expect similar sales in the fourth quarter. …
  continue reading
 
Audio roundup of selected biopharma industry content from Scrip over the business week ended 25 October 2024. In this episode: Merck & Co’s Modifi acquisition; scenarios for new obesity drugs; Astellas gets US approval for claudin drug Vyloy; iTeos builds TIGIT lead; and execs discuss AI in clinical trials.https://insights.citeline.com/scrip/quick-…
  continue reading
 
Get the full 2 hour interviews with THC+: Subscribe via our website and get the Plus show on your usual podcast apps. Subscribe via Patreon, including the full Plus archive, a dedicated RSS feed, Spotify, & payment through Paypal. Subscribe via check, cash, money order, or crypto with the information at the bottom of the page. About Today’s Guest: …
  continue reading
 
Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma e Biotech world. A study has found that Novo Nordisk's semaglutide may reduce the risk of Alzheimer's disease by 40% to 70%. Roche has entered a potential $1 billion gene therapy deal with Dyno Therapeutics, focusing on neurological diseas…
  continue reading
 
In this episode, host Stacey Richter and guest Brendan Keeler dive deep into the significant legal clash between Epic and Particle over electronic health record (EHR) data access and market competition. To Read the Show Notes with Mentioned Links and a Full Transcript, Visit the Episode Page. This episode examines the broader repercussions on healt…
  continue reading
 
Good morning from Pharma and Biotech Daily: the podcast that gives you only what's important to hear in Pharma and Biotech world.Roche CEO opposes Novo Holdings' acquisition of Catalent, urging for it to be blocked. Roche exceeded Q3 sales expectations, driven by the success of drugs like Ocrevus and Vabysmo. Pfizer's RSV vaccine has been approved …
  continue reading
 
Join us as we welcome back Dr. Veera Rajagopal, a discovery scientist at Regeneron with an interest in human genetics and drug target discovery in neuroscience and psychiatry. If you’re a regular listener of The Genetics Podcast, you may be familiar with Dr. Veera’s annual round-up episodes, and more recently, his quarterly appearances on the show.…
  continue reading
 
Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma and Biotech world. Roche has ended its collaboration with UCB on Alzheimer's treatments, marking the third candidate dropped by Roche this year. Meanwhile, activist investor Starboard has set its sights on Kenvue, a division of J&J, follow…
  continue reading
 
This week, Natan Linder, Co-Founder and CEO of Tulip sits down with Tulip CMO Madilynn Castillo to reflect on the second annual Operations Calling conference and what it means for the future of frontline operations. Natan and Madi discuss what makes Operations Calling more than just another user conference, the importance of authenticity, and build…
  continue reading
 
Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma and Biotech world.## Breakthrough in Cancer ResearchIn a groundbreaking study published in Nature Medicine, researchers have identified a new potential target for cancer therapy. This discovery could lead to more effective treatments for a…
  continue reading
 
In this enlightening episode of Pharma Marketing Playbook, join host Saumya Prakash as she converses with industry veteran Dr. P.K. Rajput. Explore Dr. Rajput's exceptional journey from a field officer to a senior vice president at Cadila Pharmaceuticals. Delve into the evolution of pharma marketing with AI and data analytics, strategic insights in…
  continue reading
 
Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma and Biotech world. ## New Drug Approval: Title: FDA Approves New Cancer Drug for Treatment of Breast CancerContent: The FDA has approved a new cancer drug for the treatment of breast cancer. This new drug is expected to provide better outc…
  continue reading
 
Audio roundup of selected biopharma industry content from Scrip over the business week ended 18 October 2024. In this episode: J&J looks to Tremfya as Stelara declines; Pfizer’s Hympavzi may find hemophilia B niche; big pharma’s cell and gene therapy realities; M&A took a holiday in Q3; and last rites for Sanofi’s RIPK1 drug.https://insights.citeli…
  continue reading
 
Send us a text What does the FDA jurisdiction for LDTs mean for the labs? Do they need to worry? How do they need to change the way they operate? In this episode, I talk with Dr. Thomas Nifong, a clinical pathologist and VP of CDX operations at Acrovan Therapeutics, about the recent FDA ruling on laboratory-developed tests (LDTs) issued on May 6th,…
  continue reading
 
Get the full 2 hour interviews with THC+: Subscribe via our website and get the Plus show on your usual podcast apps. Subscribe via Patreon, including the full Plus archive, a dedicated RSS feed, Spotify, & payment through Paypal. Subscribe via check, cash, money order, or crypto with the information at the bottom of the page. About Today’s Guest: …
  continue reading
 
Pink Sheet reporter and editors discuss an emerging pharma strategy to avoid Medicare price negotiations (:25), legal wrangling related to compounding GLP-1 drugs for obesity and diabetes (14:20), and the varying opinions of FDA officials on the acceptability of artificial intelligence models that are not fully explainable (29:08)#pharma #businessM…
  continue reading
 
Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma and Biotech world. Sanofi has signed a $326 million deal with Orano Med for radiopharma, following a similar deal made in September. Sage Therapeutics is laying off 33% of employees to support the launch of its postpartum depression drug. …
  continue reading
 
Send us a text In this episode, I had a fascinating conversation with Candice Chu, DVM, PhD, DACVP, about how artificial intelligence (AI) is reshaping veterinary diagnostics and education. Candice, a clinical pathologist and educator at Texas A&M, is using AI tools like ChatGPT to improve efficiency in clinical workflows and academic processes. We…
  continue reading
 
0:00 Invitation to The Genetics Podcast meet up 1:30 Intro to The Genetics Podcast 2:25 Welcome to Mark 3:10 Introduction to the National Institute for Health Research (NIHR) 4:05 Mark’s roles with the NIHR in strategic partnerships 7:35 Challenges patients face in accessing NHS resources and the NIHR’s efforts to streamline availability 13:25 How …
  continue reading
 
In this episode, host Stacey Richter delves into the complexities of the Third Party Administrator (TPA) Request for Proposal (RFP) process with guest Claire Brockbank from 32BJUnion. The discussion highlights the critical role of contracts in managing health plans effectively and the potential pitfalls of accepting contracts crafted by TPAs withou…
  continue reading
 
Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma and Biotech world.The FDA has paused Novavax's investigational flu and COVID-flu vaccines due to a serious adverse event of motor neuropathy. This affects their COVID-flu combo and standalone flu vaccines, which were about to enter phase I…
  continue reading
 
빅파마들은 세포유전자 치료제를 출시하면서 이러한 치료의 비용과 복잡성이라는 현실적인 문제에 직면해 있습니다. 최근 개최된 메사 세포유전자 회의를 취재한 Scrip 기사를 요약한 내용입니다. https://scrip.citeline.com/SC151041/Big-Pharma-Faces-Cell-And-Gene-Therapy-Market-RealitiesPlaylist: soundcloud.com/citelinesounds/sets/korean-language-biopharma-mini저자 Citeline
  continue reading
 
Join Margaret Uhrich as she chats with Martin Brown of Steel Sports about transforming youth sports into a powerhouse for positive change. Dive into an episode that weaves the Steel Sports coaching philosophy, inspired by Tommy Lasorda, into an intriguing narrative of data-driven success and character-building, both on and off the field. Here are a…
  continue reading
 
Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma and Biotech world.##Breaking News: FDA Approves New Cancer DrugIn a groundbreaking development, the FDA has approved a new cancer drug that has shown promising results in clinical trials. The drug is expected to provide hope for patients w…
  continue reading
 
Dexter Yan回顾了他在国庆长假前和阿斯利康全球执行副总裁-生物制药研发负责人Sharon Barr的采访。此外,本期播客迎来了Citeline Insights团队在上海的新成员、资深记者Xu Hu。她分享了先为达生物伊诺格鲁肽的最新III期临床数据,以及中国律师对美国生物安全法案影响的分析。저자 Citeline
  continue reading
 
Send us a text In this episode, Dr. Richard Fox shares how AI is transforming veterinary diagnostics. From his early career to the world of AI, Dr. Fox offers practical insights into the challenges, opportunities, and innovations that AI brings to pathology. Tune in to learn how AI is enhancing workflow efficiency, diagnostic precision, and the fut…
  continue reading
 
In this exciting episode of the Pharma Marketing Playbook, Data Gen AI and Beyond, where Saumya Prakash, co-founder at Multiplier AI, hosts Mr. Prashant Menon, a distinguished leader in the pharmaceutical industry. Explore Prashant’s comprehensive journey from field sales to senior management roles across top Indian MNCs like CIPLA and Sun Pharma, …
  continue reading
 
Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma e Biotech world.Danish pharmaceutical company Lundbeck has announced a $2.6 billion deal to acquire Longboard Pharmaceuticals, gaining access to their epilepsy drug currently in late-stage development. The FDA's accelerated approval pathwa…
  continue reading
 
Audio roundup of selected biopharma industry content from Scrip over the business week ended 11 October 2024. In this episode: making cell and gene therapies more accessible; Roche’s obesity plans; Biosecure and Indian firms; IPOs begin to recover; and Nxera looks to the future.https://scrip.citeline.com/SC151048/Quick-Listen-Scrips-Five-MustKnow-T…
  continue reading
 
Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma and Biotech world.Roche has received regulatory approval for its breast cancer drug, inavolisib, for advanced breast cancer, projecting $2.3 billion in peak sales. This drug is seen as a potential competitor to Novartis' pi3k inhibitor piq…
  continue reading
 
Introduction: Pink Sheet reporter and editors discuss experts’ experience helping drug sponsors negotiate prices with CMS (:33) and the FDA’s proposal for a new pathway to update vaccines before a pandemic is declared (12:02).More On These Topics From The Pink Sheet:Perspectives From The Front Lines: Navigating The First Round Of Medicare Price Neg…
  continue reading
 
Send us a text In this 14th episode of DigiPath Digest, I introduce a new course on AI in pathology, designed to help pathologists understand and confidently navigate AI technologies. The episode focuses on various research studies that highlight the integration and effectiveness of AI in pathology, particularly in colorectal biopsies and kidney tr…
  continue reading
 
Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma and Biotech world.GSK has settled Zantac lawsuits for $2.2 billion, resolving 93% of product liability cases regarding allegations that the heartburn drug could cause cancer. Analysts are now shifting focus to the company's vaccines busine…
  continue reading
 
0:00 Invitation to our first in-person podcast event 1:30 Intro to The Genetics Podcast 2:20 Welcome to Paul 2:53 Adeno-associated virus (AAV) biology and its advantages over other viral vectors 5:20 The gene therapy landscape and options for therapy development and delivery 6:49 The limitations of working with AAV to deliver gene therapy, includin…
  continue reading
 
In this episode I interview Cora Opsahl from the 32BJ Health Fund to examine the intricate dynamics between fiduciary duties and the entrenched status quo in healthcare. The discussion focuses on the challenges employers face when dealing with anti-competitive contracts and their responsibility to ensure plan expenses are reasonable. Cora Opsahl, m…
  continue reading
 
Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma e Biotech world.This week's commercialization news includes updates on Zepbound supply, Enjaymo's new home, and expanding access to HIV drugs. Medicare has tweaked rules for drug price talks, while GSK reports that its RSV vaccine protects…
  continue reading
 
Send us a text Good morning, digital pathology trailblazers! Welcome to another exciting exploration of digital pathology and AI. I’m thrilled to have our global community here with us today from so many different time zones. Before we dive into today's content, a quick note: my equipment is being a bit finicky, but that’s life in the digital world…
  continue reading
 
Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma e Biotech world.Sage has decided to discontinue the development of its Alzheimer's drug candidate, dalzanemdor, after disappointing mid-stage readouts. This is the third setback in neurology for the company in six months. Meanwhile, cell a…
  continue reading
 
This week’s guest is Daniele Iacovelli, VP, Global Head of Digital, Analytics (AI) & Operational Excellence at Roche. Although regulated industries like pharmaceutical manufacturing can be slow to digitally transform their manufacturing operations, Daniele lays out how changing trends in the industry have led Roche to architect a new digital produc…
  continue reading
 
Get the full 2 hour interviews with THC+: Subscribe via our website and get the Plus show on your usual podcast apps. Subscribe via Patreon, including the full Plus archive, a dedicated RSS feed, Spotify, & payment through Paypal. Subscribe via check, cash, money order, or crypto with the information at the bottom of the page. About Today’s Guest: …
  continue reading
 
Loading …

빠른 참조 가이드